Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Psychosom Med ; 2023 Apr 06.
Article in English | MEDLINE | ID: covidwho-2302572

ABSTRACT

OBJECTIVE: The general objective of the current study was to investigate the efficacy of a novel self-help virtual therapeutic experience (specifically, the COVID Feel Good intervention) in lowering the psychological burden experienced during the COVID-19 lockdowns in four European countries. METHODS: We focused on participants recruited from June 2020 to May 2021 in the context of a European multicenter project including four university/academic sites. The total number of participants in the longitudinal studies was 107 (Study 1- N = 40; Study 2: N = 29; Study 3: N = 38). The randomized controlled trial (Study 4) included 31 participants in total, 16 in the intervention group and 15 in the control group. Primary outcome measures were depression, anxiety, stress symptoms, perceived stress level, and perceived hopelessness. The secondary outcome was experienced social connectedness. RESULTS: Using separate linear mixed-effect models, the most consistent result across countries was a reduction in perceived stress following the participation in the COVID Feel Good intervention. By pooling the results of the models using a random-effect meta-analysis, we found that after the COVID Feel Good intervention, participants reported a decrease in perceived general distress [mean standardized effect size for general distress in the treatment groups compared to the control conditions was -0.52 (p = 0.008, 95% CI: -0.89, -0.14)] and an increase in the perceived social connection [mean standardized effect size for social connection using COVID Feel Good compared to the control conditions was 0.50 (p = < 0.001, 95% CI: 0.25, 0.76)]. CONCLUSION: Findings of this study indicate that a virtual self-help intervention is effective in reducing psychological distress. These results contribute to the growing literature supporting the use of digital psychological therapies to relieve psychological distress among the general population during the COVID-19 pandemic.Trial registration: ISRCTN63887521.

2.
Int J Environ Res Public Health ; 18(15)2021 08 02.
Article in English | MEDLINE | ID: covidwho-1335089

ABSTRACT

The aim of this study is to investigate the effectiveness of a novel self-administered at-home daily virtual reality (VR)-based intervention (COVID Feel Good) for reducing the psychological burden experienced during the COVID-19 lockdown in Italy. A total of 40 individuals who had experienced at least two months of strict social distancing measures followed COVID Feel Good between June and July 2020 for one week. Primary outcome measures were depression, anxiety, and stress symptoms, perceived stress levels, and hopelessness. Secondary outcomes were the experienced social connectedness and the level of fear experienced during the COVID-19 pandemic. Linear mixed-effects models were fitted to evaluate the effectiveness of the intervention. Additionally, we also performed a clinical change analysis on primary outcome measures. As concerning primary outcome measures, participants exhibited improvements from baseline to post-intervention for depression levels, stress levels, general distress, and perceived stress (all p < 0.05) but not for the perceived hopelessness (p = 0.110). Results for the secondary outcomes indicated an increase in social connectedness from T0 to T1 (p = 0.033) but not a significant reduction in the perceived fear of coronavirus (p = 0.412). Among these study variables, these significant improvements were maintained from post-intervention to the 2-week follow-up (p > 0.05). Results indicated that the intervention was associated with good clinical outcomes, low-to-no risks for the treatment, and no adverse effects or risks. Globally, evidence suggests a beneficial effect of the proposed protocol and its current availability in 12 different languages makes COVID Feel Good a free choice for helping individuals worldwide to cope with the psychological distress associated with the COVID-19 crisis, although large scale trials are needed to evaluate its efficacy.


Subject(s)
COVID-19 , Psychological Distress , Virtual Reality , Communicable Disease Control , Depression/therapy , Follow-Up Studies , Humans , Pandemics , SARS-CoV-2 , Stress, Psychological/therapy
SELECTION OF CITATIONS
SEARCH DETAIL